Home Healthcare Medical Devices Medical Oxygen Concentrators Market

Medical Oxygen Concentrators Market Size, Share & Trends Analysis Report By Type (Portable, Stationary), By Technology (Continuous Flow, Pulse Flow), By End-User (Home Care Settings, Hospitals, Ambulatory Surgical Centers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: October 07, 2026 | Author: Debashree Bora | Format:

Medical Oxygen Concentrators Market Size & Growth Analysis

The global medical oxygen concentrators market size was valued at USD 1.54 billion in 2025 and is projected to grow from USD 1.68 billion in 2026 to USD 3.35 billion by 2034, registering a CAGR of 9.01% during the forecast period from 2026 to 2034. North America dominated the medical oxygen concentrators market with a market share of 38.5% in 2025.

Medical oxygen concentrators are electrically powered medical devices that extract oxygen from ambient air and deliver a concentrated supply of oxygen to patients requiring supplemental oxygen therapy. They use technologies such as molecular sieve adsorption to separate nitrogen from oxygen and provide continuous or pulse-dose oxygen delivery. These devices are commonly used in hospitals, clinics, emergency care, and home healthcare settings for patients with respiratory conditions.

Medical Oxygen Concentrators Market Key Takeaways

Global Market Size & Growth

2025 Market Size
USD 1.54 Billion
2026 Market Size
USD 1.68 Billion
2034 Projected Market Size
USD 3.35 Billion
Forecast Period
2026-2034
Base Year
2025
Market CAGR (2026-2034)
9.01%

Regional Insights

Largest Regional Market (2025)
North America
North America Market Share (2025)
38.5%
Fastest-Growing Region
Asia Pacific
Asia Pacific CAGR (2026-2034)
8.15%

Segment Insights

By Type
Leading Segment
Portable
Market Share in 2025 57.6%
By Technology
Fastest-Growing Segment
Pulse Flow
CAGR 7.75% (2026-2034)
By End User
Leading Segment
Home Care Settings
Market Share in 2025 49.3%
Medical Oxygen Concentrators Market Size

Download a Free Sample To learn more about this report.

Medical Oxygen Concentrators Market Dynamics

01

Remote Oxygen Supply and Emergency Care Drive Market

The need for dependable oxygen access in remote areas creates requirements for on-site oxygen-generation equipment that reduces reliance on distant cylinder supply chains. WHO reports that fewer than half of health facilities in low- and middle-income countries have uninterrupted access to medical oxygen, while oxygen concentrators are suitable where cylinders or piped systems are unavailable. For example, WHO reported that a remote hospital in kiritimati, kiribati, previously depended on oxygen-cylinder shipments transported more than 3,320 km from south tarawa. This supply challenge supports the use of oxygen-generation equipment and encourages suppliers to provide durable systems for remote healthcare facilities.

The need for immediate oxygen support creates requirements for reliable oxygen sources across emergency and critical-care settings. WHO identifies oxygen as essential for surgery, trauma, intensive care, emergency transport, and the management of respiratory illnesses and hypoxaemia. For example, an emergency department can use an oxygen concentrator as an on-site oxygen source for eligible patients requiring supplemental oxygen when other supply options are limited. This clinical requirement supports procurement of oxygen concentrators by hospitals, emergency units, and healthcare facilities.

01

Operating Noise and Maintenance Requirements Restrain Market Expansion

Noise and heat generation during operation can affect patient comfort and the suitability of oxygen concentrators for home-based and long-term use. The WHO technical specifications for oxygen concentrators include requirements for noise levels and thermal management, reflecting the importance of these factors in device performance and usability. These operating limitations can reduce user acceptance and slow the adoption of medical oxygen concentrators.

Filter replacement and consumable requirements can increase the maintenance needs of medical oxygen concentrators over their operating life. WHO specifications identify filters and regular maintenance as important components of oxygen concentrator operation, with maintenance requirements varying by device design and operating conditions. These recurring maintenance needs can increase the total cost of ownership and limit adoption in resource-constrained healthcare settings.

01

High-Flow Oxygen Systems and Home Healthcare Partnerships Offers Growth Opportunities

Medical device manufacturers, hospitals, long-term care facilities, and respiratory-care providers can serve patients who require higher oxygen flow through specialized concentrators. CAIRE’s NewLife Intensity 10 delivers up to 10 LPM and can supply two patients simultaneously in its dual-flow configuration, creating revenue through specialized devices, accessories, and maintenance services.

Oxygen equipment manufacturers, home healthcare companies, and respiratory-care providers can collaborate on equipment supply, technical support, and patient-care services. Philips provides dedicated support, ordering, training, repair, and rental-contract services for homecare providers, creating recurring revenue through equipment, supplies, and service agreements.

01

Skilled Service Shortages and After-Sales Requirements Hinders Growth

Concentrators require periodic servicing, performance checks, troubleshooting, and component replacement to maintain reliable oxygen output. Shortages of trained biomedical personnel can affect the operation and maintenance of medical equipment, particularly in low- and middle-income settings. Limited availability of trained technicians can delay repairs, increase service costs, and make expansion into remote healthcare facilities more difficult.

Manufacturers must provide installation support, user training, maintenance, spare parts, and technical assistance, particularly for home-care and remote healthcare applications. Effective oxygen systems require equipment installation, commissioning, maintenance, spare parts, user training, and technical support. These requirements increase lifecycle service costs and can make geographic expansion more difficult where local support networks are limited.

Medical Oxygen Concentrators Market Segmentation

By Type

The portable segment accounted for a 57.6% share in 2025 and is expected to grow at a CAGR of 7.65% during the forecast period 2026-2034, driven by increasing demand for home-based oxygen therapy, greater patient mobility, and the growing preference for compact and easy-to-use respiratory support devices. the lightweight design, convenient transportation, and suitability for continuous oxygen therapy further strengthen the segment’s dominant position in the medical oxygen concentrators market.

The stationary segment remains important for hospitals, clinics, and homecare settings requiring reliable and continuous oxygen delivery. the higher oxygen output, stable operation, and suitability for long-duration therapy support continued adoption of stationary oxygen concentrators.

Medical Oxygen Concentrators Market Size By Segments

Request Customizationto receive a tailored report.

By Technology

The continuous flow segment accounted for a 61.8% share in 2025, owing to its ability to provide a steady supply of oxygen, suitability for patients requiring continuous therapy, and widespread use across homecare and clinical settings. the reliable oxygen delivery, consistent performance, and compatibility with long-duration respiratory care further strengthen the segment’s dominant position in the medical oxygen concentrators market.

The pulse flow segment is expected to grow at a CAGR of 7.75% during the forecast period 2026-2034, driven by increasing demand for portable oxygen therapy, growing preference for battery-operated devices, and rising adoption among mobile patients. the ability to deliver oxygen based on inhalation patterns, improve device efficiency, and extend battery life further supports the segment’s growth.

By End User

The home care settings segment accounted for a 49.3% share in 2025 and is expected to grow at a CAGR of 7.55% during the forecast period 2026-2034, supported by the increasing preference for home-based oxygen therapy, rising prevalence of chronic respiratory conditions, and growing demand for convenient long-term respiratory care. the portability and ease of use of oxygen concentrators further support their adoption among patients requiring continuous or supplemental oxygen at home.

The hospitals segment remains an important end user due to the need for reliable oxygen therapy across inpatient and emergency care, while ambulatory surgical centers use oxygen concentrators to support patients during procedures and recovery. the others segment includes additional healthcare settings where oxygen concentrators support diverse respiratory care requirements.

Medical Oxygen Concentrators Market Share By Segments

Speak to an Analystto discuss market opportunities.

Medical Oxygen Concentrators Market Regional Outlook

North America Medical Oxygen Concentrators Market Analysis

The North America medical oxygen concentrators market accounted for the largest regional share of 38.5% in 2025, supported by advanced healthcare infrastructure, high adoption of home-based oxygen therapy, and increasing demand for portable respiratory care devices. The U.S. medical oxygen concentrators market is supported by continued regulatory oversight and product activity for oxygen-generating devices. In april 2026, the FDA posted a Class II recall for the React Health PHOENIX 5L oxygen concentrator, covering two units distributed in New York, after the manufacturer identified devices that did not meet internal quality specifications. The FDA record was last updated on september 15, 2026, demonstrating continued post-market monitoring of oxygen concentrator safety and quality in the U.S. medical device market.

The Canada medical oxygen concentrators market is supported by continued licensing of new oxygen-concentrator devices. health canada issued a Class II medical-device licence on march 20, 2026, for the portable oxygen concentrator manufactured by jiangsu jumao x-care medical equipment Co., Ltd. In addition, health canada issued a Class II licence on July 3, 2026, for the oxylis s5 quiet oxygen concentrator, indicating continued introduction of oxygen-concentrator products into the canadian medical-device market.

North America Medical Oxygen Concentrators Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific Medical Oxygen Concentrators Market Analysis

The Asia Pacific medical oxygen concentrators market is expected to grow at a CAGR of 8.15% during the forecast period 2026-2034, showcasing the fastest-growing regional market, fueled by expanding healthcare access, rising prevalence of respiratory disorders, and increasing adoption of home healthcare solutions.

The Japan medical oxygen concentrators market is supported by continued use of oxygen concentrators in home oxygen therapy, with the ministry of health, labour and welfare updating guidance on fire safety during home oxygen therapy in july 2026 and specifically covering oxygen concentrators, liquid oxygen, and oxygen cylinders used for home treatment. The China medical oxygen concentrators market is driven by continued investment in hospital oxygen-generation infrastructure, with Jilin University First Hospital planning procurement of a new oxygen-generation system with a capacity of 47 m³/hour per unit in june 2026, alongside centralized procurement measures for medical equipment at public healthcare institutions introduced in july 2026.

The South Korea medical oxygen concentrators market is supported by continued development of medical-device infrastructure and respiratory-care equipment under the country’s medical-device regulatory framework, with current 2026 healthcare-equipment procurement and regulatory activity supporting oxygen-delivery technologies across medical institutions. The India medical oxygen concentrators market is fueled by continued strengthening of medical oxygen infrastructure and respiratory-care capacity, with government healthcare procurement programs including medical oxygen and respiratory-care equipment to support access to oxygen-delivery technologies.

Europe Medical Oxygen Concentrators Market Analysis

The Europe medical oxygen concentrators market accounted for a regional share of 27.2% in 2025, owing to well-developed healthcare systems, growing demand for respiratory support devices, and increasing adoption of home-based medical care. In the U.K. medical oxygen concentrators market, demand is supported by continued use of home oxygen therapy for patients requiring supplemental oxygen. NHS guidance confirms that home oxygen concentrators are supplied to named patients through healthcare-provider arrangements, while U.K. safety guidance states that oxygen therapy may be delivered through cylinders or concentrators and that equipment should be prescribed, supplied, and maintained by recognized healthcare providers.

In the Germany medical oxygen concentrators market, the established medical-device regulatory framework is supporting product traceability and oversight. From may 28, 2026, newly marketed medical devices must be registered in EUDAMED, while existing devices that continue to be placed on the market must be registered by November 28, 2026, strengthening regulatory oversight of applicable oxygen-concentrator equipment. Meanwhile, the France medical oxygen concentrators market is driven by continued assessment of oxygen-therapy technologies. In june 2026, the Haute Autorité de santé initiated a reassessment of clinical-evidence requirements for mobile oxygen concentrators, while in February 2026 it assessed the P2-TOC transportable mobile oxygen concentrator as providing sufficient expected benefit for long-term oxygen therapy in eligible patients requiring continuous oxygen at flows of up to 3 L/min.

Medical Oxygen Concentrators Market Competitive landscape

The medical oxygen concentrators market is moderately fragmented, with medical device manufacturers, respiratory care companies, home healthcare equipment providers, oxygen therapy solution suppliers, and specialized oxygen concentrator manufacturers competing across hospitals, clinics, home healthcare, and emergency care applications. Established players compete primarily on oxygen purity, flow rate, device reliability, energy efficiency, portability, noise levels, battery performance, product durability, regulatory compliance, research and development, clinical support, and global distribution networks. The leading players in the medical oxygen concentrators market include inogen inc., koninklijke philips n.v., chart industries, inc., invacare corporation, and devilbiss healthcare llc, with the top five players estimated to account for approximately 50% of the global market based on their product portfolios, technological capabilities, geographic presence, and competitive positioning.

Emerging and regional players compete through cost-effective devices, compact and lightweight designs, improved battery life, portable oxygen delivery solutions, user-friendly interfaces, customized configurations, localized manufacturing, competitive pricing, and rapid product development within the medical oxygen concentrators market ecosystem. These players also focus on developing portable oxygen technologies, improving energy efficiency, and expanding application-specific solutions to differentiate their offerings and broaden their market reach.

List of Key and Emerging Players in Medical Oxygen Concentrators Market

Oxymed
Rhythm Medical Devices
Inogen Inc.
Koninklijke Philips N.V
Chart Industries, Inc
Invacare Corporation
DeVilbiss Healthcare LLC
Nidek Medical
Inogen
O2 Concepts
Teijin Limited
Supera Anesthesia Innovations
GCE Group

Key Industry Developments

March 2026
Philips expanded its respiratory care portfolio with advanced oxygen therapy solutions, including next-generation oxygen concentrator technologies designed to improve home-based respiratory care, portability, and patient monitoring capabilities.
January 2026
Inogen expanded its portable oxygen concentrator portfolio with upgraded devices featuring improved battery performance, lightweight designs, and enhanced mobility support for patients requiring long-term oxygen therapy.
October 2025
ResMed expanded its respiratory care solutions portfolio with enhanced home respiratory technologies, integrating digital monitoring capabilities to support patients managing chronic respiratory conditions.
August 2025
Drive DeVilbiss Healthcare expanded its oxygen therapy product portfolio with new portable and stationary oxygen concentrator solutions designed to improve reliability, energy efficiency, and patient convenience.

Report Scope

Segmentation

By Type 2
  • Portable
  • Stationary
By Technology 2
  • Continuous Flow
  • Pulse Flow
By End-User 4
  • Home Care Settings
  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 8
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Singapore
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage Oxymed · Rhythm Medical Devices · Inogen Inc. · Koninklijke Philips N.V · Chart Industries, Inc
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The medical oxygen concentrators market size is valued at USD 1.68 Billion in 2026 and is projected to reach USD 3.35 Billion by 2034, at a CAGR of 9.01% during the forecast period 2026-2034.

North America dominated the market with a share of 38.5% in 2025.

The leading players in this market are Oxymed, Rhythm Medical Devices, Inogen Inc., Koninklijke Philips N.V, Chart Industries.

The medical oxygen concentrators market is projected to grow at a CAGR of 9.01% during the forecast period of 2026 2034.
About the Author
Debashree Bora
Debashree Bora
Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now

We are featured on: